Univest
Univest
  • Markets

Shilpa Medicare (SHILPAMED) Share Price rises 5.58% as stock trades at Rs 892.10

  • October 1, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Shilpa Medicare Share Price
Shilpa Medicare Ltd. (SHILPAMED) share price rose to Rs 892.1 today, up 5.58% from the previous close. Market cap was Rs 17,131.99 crore.

Shilpa Medicare Share Price moved higher today, with the stock last traded at Rs 892.10, up 5.58%, and a market capitalisation of Rs 17,131.99 crore. The latest Univest figures show an intraday move that placed Shilpa Medicare Share Price among the notable risers in the Healthcare space as investors tracked the price action, valuation and sector context. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the move relevant as a clean market reaction to the latest numbers rather than to a stated news trigger. For readers following Shilpa Medicare Share Price Today, the key questions are how the move compares with the prior close, what the valuation implies, and whether the company’s fundamentals and peer set support the current level.

Table of Contents

Toggle
  • Shilpa Medicare Share Price Today: Price Action Analysis
  • Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Shilpa Medicare Ltd.
  • About Shilpa Medicare Ltd.
  • Frequently Asked Questions
    • Why is Shilpa Medicare Share Price rising today?
    • What is Shilpa Medicare Share Price today?
    • What is the market capitalisation of Shilpa Medicare Share Price?
    • How is Shilpa Medicare Share Price valued on earnings?
    • How does Shilpa Medicare Share Price compare on book value?
    • What do ROE and ROCE say about Shilpa Medicare Share Price?
    • What is the EPS for Shilpa Medicare Share Price?
    • Does Shilpa Medicare Share Price offer a dividend yield?
  • Track Shilpa Medicare Share Price on Univest

Shilpa Medicare Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 892.1
Previous Close Rs 844.95
Today's Move Rs 47.15 (+5.58%)
Open Rs 839.95
High Rs 893.1
Low Rs 821
Market Capitalisation Rs 17,131.99 crore
Market Cap Category Mid Cap

Shilpa Medicare Ltd. (SHILPAMED) rose to Rs 892.1 from the previous close of Rs 844.95, a move of Rs 47.15 or 5.58%. The stock opened at Rs 839.95, reached a high of Rs 893.1, recorded a low of Rs 821.

Shilpa Medicare Share Price rose Rs 47.15 from the previous close of Rs 844.95, or 5.58%, and traded at Rs 892.10. The move started from an open of Rs 839.95, reached a high of Rs 893.10 and touched a low of Rs 821.00, showing a wide intraday range around the current level. This is a clear share price rise for Shilpa Medicare Share Price Today, with the stock now near the day’s high rather than the day’s low.

For traders and long-term readers of Shilpa Medicare Share Price news, the important point is that the stock is higher on the day, but the reason for the move is not established in the verified data. The current market capitalisation of Rs 17,131.99 crore also places Shilpa Medicare Share Price in a scale that merits attention in the Healthcare universe. The next section turns to Shilpa Medicare Share Price fundamental analysis to place that move in context.

Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis

Metric Value
Market Capitalisation Rs 17,131.99 crore
P/E Ratio 55.58x
P/B Ratio 6.15x
ROE 9.82%
ROCE 11.43%
EPS Rs 15.2
Book Value Per Share Rs 137.34
Dividend Yield 0.07%

Shilpa Medicare Ltd. (SHILPAMED) fundamental metrics show P/E 55.58x, P/B 6.15x, ROE 9.82%, ROCE 11.43%. These figures provide context only and are not a buy or sell signal.

Shilpa Medicare Ltd. has a market capitalisation of Rs 17,131.99 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.58x, P/B at 6.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.07%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.23x, median ROE of 11.33%, median ROCE of 13.25%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 55.58x
Benchmark Median P/E 31.23x
Benchmark Average P/E 45.39x
Benchmark P/E Range 3.4x to 616.23x
Company P/B Ratio 6.15x
Benchmark Median P/B 2.71x
Company ROE 9.82%
Benchmark Median ROE 11.33%
Company ROCE 11.43%
Benchmark Median ROCE 13.25%
Company Market Capitalisation Rs 17,131.99 crore
Benchmark Median Market Cap Rs 771.43 crore

Shilpa Medicare Ltd. (SHILPAMED) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 55.58x, which is above the benchmark median of 31.23x, a difference of +77.97%. On its own, the P/E gap is a valuation reference point, not a trading call.

Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.33%, a difference of -13.33%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.25%, a difference of -13.74%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,18,683.95 34.61 4.84 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,41,310.94 83.04 13.75 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,73,078.79 78.96 19.19 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,11,433.99 99.43 19.28 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,11,022.18 24.7 4.13 19.69 21.39

Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 55.58x compared with the displayed peer median of 78.96x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 9.82% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 17,131.99 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Shilpa Medicare Ltd.

  • Shilpa Medicare Share Price rose 5.58% today, with the stock trading at Rs 892.10 and holding close to the day’s high.
  • Shilpa Medicare Share Price has a market capitalisation of Rs 17,131.99 crore, which keeps it firmly relevant in Healthcare stock analysis.
  • Shilpa Medicare Share Price trades at a P/E of 55.58 and a P/B of 6.15, both above the same-industry medians.
  • Shilpa Medicare Share Price shows ROE of 9.82% and ROCE of 11.43%, which sit below the benchmark median levels.
  • Shilpa Medicare Share Price remains useful to track because the latest Univest data confirms the price event, while no company-specific catalyst is established.

About Shilpa Medicare Ltd.

Shilpa Medicare Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s business is associated with pharmaceutical activity, and its market position can be read through the latest numbers on Shilpa Medicare Share Price, market capitalisation, valuation and return ratios. For investors studying Shilpa Medicare Share Price, the company profile matters because it links the trading move to a larger operating base rather than to a one-day chart change alone.

The company’s current market capitalisation of Rs 17,131.99 crore places it above the same-industry median size, while its P/E of 55.58 and P/B of 6.15 show a valuation that sits above the benchmark median. ROE of 9.82% and ROCE of 11.43% provide the return context, and EPS of Rs 15.2 with book value of Rs 137.34 per share gives a clearer picture of the per-share economics behind Shilpa Medicare Share Price. Dividend yield of 0.07% indicates that income contribution is limited compared with the price and valuation narrative.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Shilpa Medicare Share Price rising today?

Ans. Shilpa Medicare Share Price rose 5.58% to Rs 892.10 today. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read as verified price action.

What is Shilpa Medicare Share Price today?

Ans. Shilpa Medicare Share Price today is Rs 892.10. The stock gained Rs 47.15 from the previous close of Rs 844.95, making it one of the notable rising stocks in the Healthcare space.

What is the market capitalisation of Shilpa Medicare Share Price?

Ans. Shilpa Medicare Share Price has a market capitalisation of Rs 17,131.99 crore. That places it above the same-industry median market cap and gives the move a meaningful size context in Pharmaceuticals & Drugs.

How is Shilpa Medicare Share Price valued on earnings?

Ans. Shilpa Medicare Share Price is trading at a P/E of 55.58. That is above the industry median of 31.23 and above the average of 45.39, which indicates a richer valuation than the benchmark centre.

How does Shilpa Medicare Share Price compare on book value?

Ans. Shilpa Medicare Share Price has a P/B of 6.15 and book value of Rs 137.34 per share. The P/B is above the sector median of 2.71 and above the average of 4.05.

What do ROE and ROCE say about Shilpa Medicare Share Price?

Ans. Shilpa Medicare Share Price shows ROE of 9.82% and ROCE of 11.43%. Both are below the same-industry medians of 11.33% and 13.25%, which adds useful context for fundamental analysis.

What is the EPS for Shilpa Medicare Share Price?

Ans. Shilpa Medicare Share Price has an EPS of Rs 15.2. EPS helps investors see earnings attributable to each share, and it is one of the key figures to read alongside valuation and return ratios.

Does Shilpa Medicare Share Price offer a dividend yield?

Ans. Shilpa Medicare Share Price has a dividend yield of 0.07%. That is a very small income component, so the stock’s current story is driven more by price action and valuation than by dividend return.

Track Shilpa Medicare Share Price on Univest

Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Shilpa Medicare Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights in one place. The platform also helps compare Shilpa Medicare Share Price with peer companies, sector benchmarks and fundamental ratios that matter for stock analysis. For ongoing Shilpa Medicare Share Price news, Univest keeps the focus on verified numbers and company context rather than speculation.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply